Ana Bosch

PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancer

Ana Bosch, Zhiqiang Li, Anna Bergamaschi et al. · Science Translational Medicine · 2015 · 436 citations

Life Sciences, Molecular Biology, Oncology +17

Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study

Johan Staaf, Dominik Głodzik, Ana Bosch et al. · Nature Medicine · 2019 · 317 citations

Medicine, Molecular Genetics, Oncology +12

Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients

Isabel Chirivella, Begoña Bermejo, Amelia Insa et al. · Breast Cancer Research and Treatment · 2008 · 174 citations · Full text

Medicine, Oncology, Pharmacology +16

Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-Negative Breast Cancer

Jessica J. Tao, Pau Castel, Nina Radosevic‐Robin et al. · Science Signaling · 2014 · 166 citations

Medicine, Oncology, Pharmacology +16

Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers

Dominik Głodzik, Ana Bosch, Johan Hartman et al. · Nature Communications · 2020 · 136 citations · Full text

Medicine, Genetics, Oncology +17